Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Metabolife defense verdict

This article was originally published in The Tan Sheet

Executive Summary

Supplement marketer's conduct did not cause an Upland, Calif. man's personal injuries, Rancho Cucamonga, Calif. state court jury concludes Dec. 12. Plaintiff Tom Hendriksen alleged he suffered a stroke at age 47 after using ephedra-containing Metabolife 356. Company argued plaintiff had numerous risk factors contraindicated on product labeling - including diabetes, hypertension, high cholesterol, atherosclerosis - and there was no proof the product caused his injury. Even though jury found Metabolife liable for design defect, negligence, false representation and concealment of a material fact, panel did not award any damages and concluded company did not breach an express warranty of safety. This is the second personal injury lawsuit to go to verdict against Metabolife and the first to result in a no damages award; an Alabama jury returned a $4.1 mil. verdict in four consolidated cases last month (1"The Tan Sheet" Nov. 25, 2002, p. 3)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094912

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel